Andrade Chittaranjan
Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India.
J Clin Psychiatry. 2021 Nov 30;82(6):21f14325. doi: 10.4088/JCP.21f14325.
Many preclinical and clinical studies have examined the potential benefits of ginger extracts for a range of medical disorders. Ginger has been found to reduce both pain and nausea and has therefore also been studied in the context of migraine headache. One randomized controlled trial (RCT) found that ginger was no better than placebo for the prevention of migraine episodes. One meta-analysis (pooled N = 227) found that, relative to placebo, ginger was associated with a higher proportion of patients who were pain free 2 hours after treatment (risk ratio [RR], 1.79; 95% confidence interval [CI], 1.04-3.09; 2 RCTs). In this meta-analysis, relative to placebo, ginger reduced the risk of migraine-related nausea and vomiting (RR, 0.48; 95% CI, 0.30-0.77; 3 RCTs) and was not associated with an increased risk of adverse events (RR, 0.80; 95% CI, 0.46-1.41; 3 RCTs). No other RCT data are available. Such an evidence base is clearly too small for formal recommendations to be possible. It is suggested that raw ginger or proprietary ginger extracts may be useful as a home remedy for patients who experience an episode of migraine and who, for whatever reason, cannot take established first-line treatments for acute migraine. How ginger thus used compares with established treatments for migraine is presently unknown. Finally, it must be remembered that the chemical constituents of ginger will vary across source and extract; so, when an extract of ginger is studied, the findings of the study can be generalized only to that extract and, possibly, to other extracts with a similar composition.
许多临床前和临床研究都探讨了姜提取物对一系列医学病症的潜在益处。人们发现姜既能减轻疼痛,又能缓解恶心,因此也对其在偏头痛方面进行了研究。一项随机对照试验(RCT)发现,姜在预防偏头痛发作方面并不比安慰剂更有效。一项荟萃分析(汇总样本量N = 227)发现,与安慰剂相比,姜与治疗后2小时无痛患者的比例更高有关(风险比[RR],1.79;95%置信区间[CI],1.04 - 3.09;2项RCT)。在这项荟萃分析中,与安慰剂相比,姜降低了偏头痛相关恶心和呕吐的风险(RR,0.48;95% CI,0.30 - 0.77;3项RCT),且与不良事件风险增加无关(RR,0.80;95% CI,0.46 - 1.41;3项RCT)。没有其他RCT数据可用。这样的证据基础显然太小,无法做出正式推荐。有人建议,对于经历偏头痛发作且因任何原因无法采用既定急性偏头痛一线治疗方法的患者,生姜或专利姜提取物可能作为一种家庭疗法有用。目前尚不清楚这样使用的姜与既定的偏头痛治疗方法相比效果如何。最后,必须记住,姜的化学成分会因来源和提取物不同而有所变化;所以,当研究一种姜提取物时,该研究结果只能推广到该提取物,可能还能推广到其他成分相似的提取物。